Nxera Pharma Co (Nxera Pharma Co) EV-to-Revenue : 11.43 (As of Apr. 25, 2024)

View and export this data going back to . Start your Free Trial

What is Nxera Pharma Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Nxera Pharma Co's enterprise value is $1,013.87 Mil. Nxera Pharma Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $88.72 Mil. Therefore, Nxera Pharma Co's EV-to-Revenue for today is 11.43.

The historical rank and industry rank for Nxera Pharma Co's EV-to-Revenue or its related term are showing as below:

SOLTF' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.03 Med: 15.93 Max: 54.71
Current: 12.09

During the past 13 years, the highest EV-to-Revenue of Nxera Pharma Co was 54.71. The lowest was 3.03. And the median was 15.93.

SOLTF's EV-to-Revenue is ranked worse than
60.99% of 1033 companies
in the Biotechnology industry
Industry Median: 7.63 vs SOLTF: 12.09

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-25), Nxera Pharma Co's stock price is $9.72. Nxera Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.07. Therefore, Nxera Pharma Co's PS Ratio for today is 9.10.

Nxera Pharma Co EV-to-Revenue Historical Data

The historical data trend for Nxera Pharma Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nxera Pharma Co EV-to-Revenue Chart

Nxera Pharma Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

15.82

13.76

7.02

8.88

11.88

Nxera Pharma Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															8.88	9.70	5.77	12.37	11.88

Competitive Comparison of Nxera Pharma Co's EV-to-Revenue

For the Biotechnology subindustry, Nxera Pharma Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nxera Pharma Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nxera Pharma Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Nxera Pharma Co's EV-to-Revenue falls into.

Nxera Pharma Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Nxera Pharma Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	1013.871	/	88.72
	=	11.43

Nxera Pharma Co's current Enterprise Value is $1,013.87 Mil.
Nxera Pharma Co's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $88.72 Mil.

Nxera Pharma Co (OTCPK:SOLTF) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Nxera Pharma Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	9.72	/	1.068
	=	9.10

Nxera Pharma Co's share price for today is $9.72.
Nxera Pharma Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.07.

Nxera Pharma Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Nxera Pharma Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Nxera Pharma Co (Nxera Pharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nxera Pharma Co Ltd (OTCPK:SOLTF) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

4565:Japan JSS:Germany

Address

2-1 Kojimachi, Chiyoda-ku, PMO Hanzomon 11th Floor, Tokyo, JPN, 102-0083

Website

http://www.sosei.com

Sosei Group Corp is an international biopharmaceutical company that develops treatments for a wide range of illnesses. The company utilizes its peptide platform technologies and nanotechnology to develop its product pipeline. Sosei actively seeks partnerships to aid its product development. The company's strategy for commercializing its therapies include utilizing its subsidiaries' drug discovery technologies, supplying technology to other companies, developing products in-house, and product licensing.